What V-Ensure Pharma Technologies does

V-Ensure Pharma Technologies is an India-based contract research, API development, and contract manufacturing organization (CRAMSO) focused on complex generic pharmaceutical formulations for regulated advanced markets. The company operates a vertically integrated platform spanning API R&D through SKVen in Hyderabad, formulation development and analytical services in Navi Mumbai, and cGMP manufacturing in a 120,000 sq ft facility in Panvel, Maharashtra. Core technical competencies include complex drug delivery systems across injectable (nano-emulsions, long-acting suspensions, lyophilized dose forms, dual-chamber PFS), solid oral (OROS osmotic release, hot-melt extrusion, multi-unit particulate systems, taste masking), and liquid oral dosage forms, supported by non-infringing process development and polymorph screening capabilities built around a pipeline of 20+ APIs and 15+ intermediates.

The business model is enterprise B2B, combining contract research services (formulation R&D, analytical R&D, API R&D, dossier and regulatory filing), contract manufacturing of finished dosage forms, and emerging-market distribution through subsidiary Pantson Pharma and downstream marketing through Creekwood Pharmaceuticals LLC. V-Ensure serves more than 35 pharmaceutical clients across Europe, North America, China, Australia, and Brazil via direct enterprise sales, with pricing structured project-by-project based on scope and complexity. The company maintains ICH stability testing capability across all climate zones and successfully cleared a US FDA inspection of its analytical facility in February 2020 without any Form 483 observation, qualifying it for advanced-market supply. Growth is funded by an INR 130 crore (approximately US$17.5 million) private equity investment from Investcorp in February 2022, earmarked for expansion in North America and Europe.

Name

V-Ensure Pharma Technologies

Legal name

V-Ensure Pharma Technologies Pvt. Ltd

Website

https://v-ensure.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

V-Ensure Pharma Technologies is an India-based contract research, API development, and cGMP manufacturing organization specializing in complex generic formulations (injectable, solid oral, liquid oral) for 35+ pharmaceutical clients across Europe, North America, China, Australia, and Brazil.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Scientific Research and Development Services (5417)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical contract manufacturing
• Complex generics development
• Formulation research services
• API development
• CGMP manufacturing

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Research & Development: Providing formulation R&D, analytical R&D, and API R&D services to pharmaceutical clients for end-to-end dossier development, non-infringing formulation and IP strategies, and regulatory filing support
2. Contract Manufacturing: cGMP manufacturing of finished dosage forms including solid oral, injectable, and liquid oral products for clients in advanced and emerging markets
3. API Development and Supply: API R&D services and manufacturing through SKVen subsidiary, developing high value key intermediates and APIs for global pharmaceutical manufacturers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

V-Ensure Pharma Technologies is a contract research and manufacturing organization that delivers end-to-end pharmaceutical development services for complex generics. Its portfolio spans formulation R&D, analytical services, API development (through SKVen), and cGMP manufacturing of finished dosage forms across injectable, solid oral, and liquid oral categories, serving global pharmaceutical clients in advanced and emerging markets.

Product overview

V-Ensure Pharma Technologies is a pharmaceutical contract research and manufacturing organization (CRO/CMO) that provides integrated services for complex generics development and commercialization. The company operates three core business verticals: Contract Research (Formulation R&D), API Development, and Contract Manufacturing. Their product portfolio spans three dosage forms—injectable (including nano-emulsions, long-acting injections, lyophilized dose forms), solid oral (OROS, hot-melt extrusions, multi-particulate systems), and liquid oral (suspensions, solutions). Services include end-to-end dossier development, regulatory filing, cGMP manufacturing, and analytical services, supported by a team of over 150 scientists across facilities in Navi Mumbai and Hyderabad, India.

Differentiator

Problem solved

Functional benefit

Products and services

• Injectable Dose Forms Pharmaceutical injectable dosage forms including emulsion-based drug delivery systems (nano-emulsions), long-acting injections with particle engineered suspensions, lyophilized dose forms, and dual chamber prefilled syringes, developed and manufactured for global pharmaceutical clients.
• Solid Oral Dose Forms Solid oral dosage forms including OROS technology platforms, hot-melt extrusions, self-micro emulsified drug delivery systems, multi-unit particulate systems, GIT retention techniques (floating and hydrogel), and taste masking technologies, produced at the 120,000 sq ft cGMP facility.
• Liquid Oral Dose Forms Liquid oral formulations including powders for oral suspension, liquid solutions, and suspensions, developed and manufactured for pharmaceutical clients.
• Contract Research & Development (Formulation R&D) End-to-end formulation development services including dossier development, non-infringing formulation and IP strategies, project management, and regulatory filing for solid oral, liquid oral, and parenteral formulations based on QbD concepts and GLP standards.
• API Development Active Pharmaceutical Ingredient (API) development services through the SKVen subsidiary, including patent landscaping, polymorph screening with non-infringing processes, development of KSMs, intermediates and APIs, regulatory DMF filing, analytical development, and technology transfer. Pipeline includes over 20 APIs and 15 intermediates.
• cGMP Manufacturing Contract manufacturing of finished pharmaceutical dosage forms including IR tablets, IR capsules, modified release tablets and capsules, pellets, mini-tabs in capsule, and granules for sachet, executed at a 120,000 sq ft cGMP manufacturing facility in Panvel, Maharashtra, serving USA, Europe, Canada, Australia and other advanced markets.
• Analytical Services Analytical method development, transfers and validations for exhibit batch manufacturing, ICH stability testing across all climate zones (Zone I, II, III, IVa, IVb), batch release and testing, supported by chromatographic, spectroscopic, and imaging systems.

Quantifiable outcome

• Successful US FDA inspection in February 2020 without any 483 notice
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Syngene International: Indian-listed CRO/CDMO offering formulation development, API and biologics manufacturing for global pharma — directly comparable to V-Ensure as an integrated, science-led contract services platform serving US/EU clients.
• Piramal Pharma Solutions: Global CDMO with strong complex generics and API capabilities, operating large cGMP facilities and serving regulated markets — comparable in service breadth, customer type, and regulatory positioning to V-Ensure.
• Laurus Labs: Indian API and formulation CDMO supplying regulated markets including the US and EU, with vertical integration from intermediates to finished dosage — directly comparable in business model and target customer base.
• Sai Life Sciences: India-based CDMO offering API development, formulation R&D, and manufacturing services for global pharmaceutical companies — closely aligned with V-Ensure's CRO/CMO service model and advanced-market focus.
• Suven Pharmaceuticals: Indian CRAMS (Contract Research and Manufacturing Services) company focused on complex API and intermediates for global pharma, with NCE and generic development capabilities comparable to V-Ensure's SKVen subsidiary.
• Aragen Life Sciences (formerly GVK Biosciences): India-headquartered CRO/CDMO with discovery, development, and manufacturing services for global pharma and biotech — comparable in scale, service scope, and customer base to V-Ensure.

Broad incumbents

• Jubilant Pharmova (CDMO division): Diversified Indian pharma group with CDMO operations including sterile injectables and APIs, serving global regulated markets — overlapping with V-Ensure in formulation, API, and contract manufacturing services.
• Dr. Reddy's Laboratories (CDMO/PSG division): Large Indian pharma company with active API and contract manufacturing services for global partners, including complex generics — comparable in CDMO capabilities, though operating at much greater scale.
• Aurobindo Pharma: Major Indian generic manufacturer with significant API, formulation, and contract manufacturing operations serving the US and EU — overlapping in target customers, dosage forms, and regulatory positioning.

Regional players

• Granules India: India-based pharmaceutical manufacturer specializing in high-volume API and finished dosage forms with a strong presence in emerging markets — comparable in solid oral and API capabilities, particularly relevant to V-Ensure's Neel Nayan Pharma emerging-markets platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about V-Ensure Pharma Technologies